More than 10% of the population aged >70 years have heart failure and the lifetime risk of heart failure at age 55 years is 33% for men and 28% for women. Despite huge advances in care over the last few decades, a diagnosis of heart failure still carries a dire prognosis, with a patient hospitalized with heart failure having a oneyear mortality risk of 17%.
More than 10% of the population aged >70 years have heart failure and the lifetime risk of heart failure at age 55 years is 33% for men and 28% for women. Despite huge advances in care over the last few decades, a diagnosis of heart failure still carries a dire prognosis, with a patient hospitalized with heart failure having a oneyear mortality risk of 17%. 1 More than 20% of hospital admissions in patients aged >65 years are due to heart failure. 2 The societal costs associated with heart failure are huge and any preventive measures that can be taken to reduce the burden of heart failure are important.
The aetiology of heart failure is heterogeneous, but most heart failure with reduced ejection fraction is caused by coronary heart disease. Smoking is a cause of coronary heart disease and thus contributes to heart failure, but also acts through other less studied mechanisms. It has previously been estimated that smoking is responsible for 17% of cases of heart failure (i.e. the population attributable fraction). 3 The meta-analysis by Aune et al. 4 supports this association. Based on data from 10 studies consisting of 3,803,792 participants and 57,004 cases of heart failure, Aune et al. 4 found that current smoking was associated with a 75% (95% CI 54-99%) increased risk of heart failure compared with never smoking. Although there was some heterogeneity and indication of publication bias, the results were consistent over various subgroups and in a series of sensitivity analyses. Only two studies had looked separately at heart failure with reduced versus preserved ejection fraction, but these indicated a similar increase in risk of heart failure with preserved ejection fraction among smokers. Importantly, in the nine studies comparing former smokers with never smokers, the risk was only 16% (CI 8-25%) higher than in never smokers.
There are two messages to be taken from this study. One is a reminder that smoking does not only cause atherosclerosis and ischaemic heart disease, but also heart failure. This may sometimes be overlooked. As pointed out by Aune et al., 4 despite heart failure being a major chronic disease, heart failure was not included in the global burden of disease estimates of the global consequences of smoking. 5 The other message is that smoking cessation is worthwhile.
Globally, 16% of all deaths in men and 7% in women are caused by smoking. In European men the proportion reaches a high of 25%. 6 Based on contemporary cohorts, the relative risk of ischaemic heart disease among smokers is about 2.50 in men and 2.86 in women. 7 There is no safe level of smoking. According to a recent meta-analysis, the relative risk of coronary heart disease with smoking even one cigarette per day was 1.74 in men and 2.19 in women, equivalent to 40-50% of the excess risk of a heavy smoker. 8 About 25% of the world's population are currently smokers. Smoking rates remain high in Europe, in particular among women. European women have the highest prevalence of smoking in the world and the future does not look bright. Globally, there are 22 countries in which >15% of girls aged 15-19 years are smokers. Eighteen of these countries are in western or central Europe. Unfortunately, there seems to be no decrease in the prevalence of smoking among young people. 5 There is a continued need for greater attention to the hazards of smoking, followed by action from those that form our policies. This meta-analysis further strengthens this need. European Society of Cardiology guidelines on smoking prevention have pointed towards the most efficient evidence-based measures, which include increasing the taxation of tobacco, enforcing smoking bans, and restrictions on marketing and advertising. 9 Population-level interventions have been proved to effective, in particular in preventing the young from starting smoking. A common goal should be a tobacco-free Europe by 2030.
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